Clinical study of tiotropium bromide in the treatment of acute exacerbation of chronic obstructive pulmonary disease complicated with acute respiratory failure
10.3969/j.issn.1673-9701.2024.04.015
- VernacularTitle:噻托溴铵治疗慢性阻塞性肺疾病急性加重期合并急性呼吸衰竭的临床研究
- Author:
Kai FU
1
,
2
;
Huibin PAN
1
,
2
;
Xiaofei ZHU
1
,
2
;
Zhuquan DAI
1
,
2
;
Pingping ZHOU
1
,
2
Author Information
1. Department of Emergency, the First People&rsquo
2. s Hospital of Huzhou, Huzhou 313000, Zhejiang, China
- Publication Type:Journal Article
- Keywords:
Chronic obstructive pulmonary disease;
Tiotropium bromide;
Respiratory failure;
Acute exacerbation
- From:
China Modern Doctor
2024;62(4):60-63
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy of tiotropium bromide in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)complicated with acute respiratory failure.Methods A total of 106 patients with AECOPD complicated with acute respiratory failure admitted to the First People's Hospital of Huzhou from March 2019 to March 2022 were selected and divided into observation group and control group according to random number table method,with 53 cases in each group.Both groups were given routine treatment.The control group was treated with noninvasive biphasic positive airway pressure ventilation.The observation group was treated with tiotropium bromide on the basis of control group.Both groups were treated for 14 days.The clinical efficacy,lung function,blood gas index,inflammatory factors and adverse reactions were compared between two groups.Results The total effective rate of observation group was significantly higher than that of control group(94.34%vs.79.25%,χ2=5.267,P=0.023).After treatment,forced expiratory volume in one second(FEV1),FEV1/forced vital capacity,peak expiratory flow,pH,percutaneous arterial oxygen saturation and arterial partial pressure of oxygen in observation group were significantly higher than those in control group(P<0.05),while arterial partial pressure of carbon dioxide,interleukin-6,interleukin-8,tumor necrosis factor-α and hypersensitive C-reaction protein were lower than those in control group(P<0.05).There were no significant differences in the incidence of adverse drug reactions and ventilator adverse reactions between two groups(P>0.05).Conclusion Titropium bromide in the treatment of AECOPD complicated with acute respiratory failure can significantly improve the curative effect,improve pulmonary function and arterial blood gas,but attention should be paid to the timely treatment of adverse reactions of dry mouth.
